Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II trial underway in Mali for CIS-43LS to prevent P. falciparum infection

March 24, 2021

MGTA-145 plus plerixafor effectively mobilizes stem cells for transplant in phase I study

March 24, 2021

Remdesivir data in pediatric patients with COVID-19

March 24, 2021

FDA approves IND for JAR-914 in Duchenne muscular dystrophy

March 24, 2021

Frequency Therapeutics reports phase IIa data on FX-322 in sensorineural hearing loss

March 23, 2021

Japanese MHLW approves Pemazyre for unresectable biliary tract cancer with FGFR2 fusion gene

March 23, 2021

Keytruda wins FDA approval for esophageal or GEJ carcinoma

March 23, 2021

Phase III VISION study of 177Lu-PSMA-617 meets primary endpoints in CRPC

March 23, 2021

Daiichi Sankyo's mRNA vaccine for COVID-19 enters phase I/II trial in Japan

March 23, 2021

Japanese approval of Arikayce for NTM lung disease caused by MAC

March 23, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...